A new blood pressure medication has been approved in the U.S., but this one isn't quite like others that help treat hypertension. Baxfendy, from pharmaceutical maker AstraZeneca, is the "first and ...

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The pulmonary arterial hypertension clinical trial ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...

AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...

Researchers at Penn State created a soft implant called CaroFlex that may help lower high blood pressure without extra medicines.

The pharmaceutical company expects the drug Baxfendy to generate multibillion-dollar annual sales at its peak.

Baxfendy inhibits a blood-pressure-raising enzyme and, according to AstraZeneca executives, is poised to be a “big product” ...

The Punjab government on World Hypertension Day said its Mukh Mantri Sehat Yojna is helping patients, including senior ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

The Nigerian Hypertension Society has raised concern over the growing burden of hypertension in Nigeria, revealing that one ...

In theory, hypertension is a disease that is both easy to test for and readily treatable with existing medications and ...

Have you been diagnosed with hypertension, or dealing with fluctuating blood pressure? Read on to know the real facts about ...